This most up-to-date twist while in the Lykos Therapeutics saga threatens A significant overhaul of the corporate’s tactic and route, with Musk ally and billionaire investor Antonio Gracias showing up to would like to just take the business back again towards its nonprofit drug growth roots and a far more Doblinite philosophy.Are you presently ab